Astellas Pharma | 4503 - Cost Of Sales


Astellas Pharma reported JPY149.13B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Astellas Pharma JPY 149.13B 10.88B Dec/2025
Chugai Pharma JPY 87.56B 12.68B Dec/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eisai JPY 51.08B 5.56B Dec/2025
Kyowa Hakko Kirin JPY 37.87B 9.67B Dec/2025
M3 JPY 45.54B 2.27B Dec/2025
Otsuka Holdings JPY 192.74B 11.78B Dec/2025
Shionogi JPY 25.65B 8.23B Dec/2025
Sumitomo Dainippon JPY 45.59B 1.48B Sep/2025
Takeda JPY 401.15B 184.07B Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025